Efficacy of a neuropsychological training programme for patients with multiple sclerosis - a randomised controlled trial

被引:0
|
作者
Tesar, N [1 ]
Bandion, K [1 ]
Baumhackl, U [1 ]
机构
[1] Landesklinikum St Polten, Neurol Abt, A-3100 St Polten, Austria
关键词
multiple sclerosis; cognitive impairments; cognitive training; compensation mechanisms; subjective everyday relevance;
D O I
10.1007/s00508-005-0470-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: One aim of this project was to investigate the efficacy of a specific training programme for MS patients, which also contained compensation strategies and relaxation exercises relevant to everyday life. The other aim was to check the programme's relevance to everyday life. Method. 19 patients, randomised into two groups, took part in the study. The participants in the treated group completed a specific neurological training programme which began immediately after the basic testing (visit 1) and lasted 4 weeks, with a total of 12 sessions. The monitoring test was done immediately after the training programme (at visit 2) and the follow-up was 3 months later (visit 3). Both study groups were fully comparable as regards clinical and socio-demographic data and baseline intelligence level. Results: The results of the cognitive training programme were especially evident in the significant improvements in executive functions (CKV) and spatial-constructional abilities (HAWIE-R). Comparison between the treated and the control group showed no significant difference in the fatigue values (MFIS). However, when the treated group was examined over the three times of measurements, the symptoms of fatigue had diminished significantly. Regarding memory, comparison of the groups showed no changes; within the treated group, however, the verbal (VLT) and non-verbal learning and memory (NVLT) improved significantly. The results for sustained attention improved in both groups over time. It must be assumed that a learning effect had occurred here. The depression values (BDI) also improved in both study groups. The follow-up questionnaire showed that 60% (6) attributed an average to above-average benefit to the training. Conclusion: To summarise, it is apparent that MS patients with mild to moderate cognitive impairment are able to profit from even a fairly brief neuropsychological training programme and to integrate much of it into their everyday lives. In view of this, it would seem appropriate to offer such a programme as standard, associated with medication.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 50 条
  • [41] Fampridine treatment and walking distance in multiple sclerosis: A randomised controlled trial
    Pickering, Hannah
    Murray, Jenna
    Lin, Cindy S. -Y.
    Cormack, Christine
    Martin, Andrew
    Kiernan, Matthew C.
    Krishnan, Arun V.
    CLINICAL NEUROPHYSIOLOGY, 2017, 128 (01) : 93 - 99
  • [42] A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis
    Khan, F.
    Pallant, J. F.
    Pallant, J. I.
    Brand, C.
    Kilpatrick, T. J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (09): : 1033 - 1038
  • [43] Evaluating preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): a feasibility cluster-randomised controlled trial
    Hynes, S. M.
    Dwyer, C. P.
    Alvarez-Iglesias, A.
    Rogers, F.
    Joyce, R.
    Oglesby, M.
    Moses, A.
    Bane, E.
    Counihan, T. J.
    Casey, D.
    Charamba, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 919 - 919
  • [44] Effectiveness of a volunteer befriending programme for patients with schizophrenia: randomised controlled trial
    Priebe, Stefan
    Chevalier, Agnes
    Hamborg, Thomas
    Golden, Eoin
    King, Michael
    Pistrang, Nancy
    BRITISH JOURNAL OF PSYCHIATRY, 2020, 217 (03) : 477 - 483
  • [45] An exploratory randomised controlled trial of a support programme for carers of patients with a psychosis
    Szmukler, G
    Kuipers, E
    Joyce, J
    Harris, T
    Leese, M
    Maphosa, W
    Staples, E
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2003, 38 (08) : 411 - 418
  • [46] An exploratory randomised controlled trial of a support programme for carers of patients with a psychosis
    G. Szmukler
    E. Kuipers
    J. Joyce
    T. Harris
    M. Leese
    W. Maphosa
    E. Staples
    Social Psychiatry and Psychiatric Epidemiology, 2003, 38 : 411 - 418
  • [47] Efficacy of a cognitive training programme for mild cognitive impairment: Results of a randomised controlled study
    Jean, Leonie
    Simard, Martine
    Wiederkehr, Sandra
    Bergeron, Marie-Eve
    Turgeon, Yves
    Hudon, Carol
    Tremblay, Isabelle
    van Reekum, Robert
    NEUROPSYCHOLOGICAL REHABILITATION, 2010, 20 (03) : 377 - 405
  • [48] Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial
    Gold, Stefan M.
    Friede, Tim
    Meyer, Bjoern
    Moss-Morris, Rona
    Hudson, Joanna
    Asseyer, Susanna
    Bellmann-Strobl, Judith
    Leisdon, Andreas
    Issels, Leonie
    Ritter, Kristin
    Schymainski, David
    Pomeroy, Hayley
    Lynch, Sharon G.
    Cozart, Julia S.
    Thelen, Joan
    Roman, Cristina A. F.
    Cadden, Margaret
    Guty, Erin
    Lau, Stephanie
    Poettgen, Jana
    Ramien, Caren
    Seddiq-Zai, Susan
    Kloidt, Anna-Maria
    Wieditz, Johannes
    Penner, Iris-Katharina
    Paul, Friedemann
    Sicotte, Nancy L.
    Bruce, Jared M.
    Arnett, Peter A.
    Heesen, Christoph
    LANCET DIGITAL HEALTH, 2023, 5 (10): : E668 - E678
  • [49] Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme
    Falkai, P.
    Reuteman-Fowler, C.
    Blahova, Z.
    Ikezawa, S.
    Marder, S. R.
    Krystal, J. H.
    EUROPEAN PSYCHIATRY, 2023, 66 : S637 - S637
  • [50] The effectiveness of a training programme in everyday cognition in healthy older adults: a randomised controlled trial
    Sanchez Gomez, Celia
    Fernandez Rodriguez, Eduardo Jose
    BMC GERIATRICS, 2021, 21 (01)